Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Berkshire Hathway 'A'

Article Abstract:

A comparative analysis of the company sales and financial details of Berkshire Hathway, Inc. from 1997 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Author: Pandolfi, Anthony P.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Fire, marine, and casualty insurance, Berkshire Hathaway Inc., BRK.A

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Ohio Casualty

Article Abstract:

Ohio Casualty Corp.'s strong results for the last quarter of 2002 resulted to from favorable loss trends in speciality lines. Shares a neutrally ranked and offer 3- to 5-year appreciation potential to risk-tolerant investors.

Author: Pandolfi, Anthony P.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Forecasts, trends, outlooks, Financial management, Labor Distribution by Employer, Evaluation, Finance, Company investment, Investments, Statistics, Ohio Casualty Corp., OCAS, Rankings, Company business forecast/projection, Company forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Securities, Company sales and earnings, Company earnings/profit, Property and casualty insurance industry, Company securities
Similar abstracts:
  • Abstracts: Allstate Corp. Berkshire Hat. 'A'
  • Abstracts: Berkley (W.R.). Berkley (W.R.)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.